$65K in pharma research grants up for grabsJuly 15, 2020AVMF, VPRF, and ACVCP are seeking proposals for research related to new or approved medications.
Education Center - SponsoredAVMA benefits: Are you leaving anything behind?by • American Veterinary Medical Association (AVMA)As the national association for veterinarians, the American Veterinary Medical Association (AVMA) provides tools and resources that help our members—and the veterinary profession as a whole—grow, advance, and succeed
Feed additives could mitigate the spread of deadly ASFJuly 7, 2020Feed additives might be the key to controlling a rapidly spreading animal virus that is killing the world’s pig population and threatening human food security.
Genetic enzymes may point to canine cancer preventionApril 15, 2020Certain dogs may be more susceptible than others to developing environmentally associated cancers.
Alternative treatment for deadly foal pneumonia revealedMarch 30, 2020Equine veterinarians may soon be equipped with a method for treating pneumonia in foals that does not promote multidrug-resistant bacteria.
COVID-19 research underway in LouisianaMarch 11, 2020Researchers at Louisiana State University School of Veterinary Medicine (LSU SVM) are hoping to develop a vaccine that could be used to prevent novel coronavirus (COVID-19) infection in humans.
Entrepreneurial success focus of academy programMarch 5, 2020Researchers and graduate students interested in exploring the marketability of their ideas may want to consider a new summer program at the University of California, Davis (UC Davis) School of Veterinary Medicine.
$2.1 million in grants fund canine cancer researchMarch 3, 2020Early-stage lymphoma, appendicular osteosarcomas, and the detection of degenerative myelopathy are among the research topics selected to receive funding from the AKC Canine Health Foundation (CHF).
K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
